FDA Panel Recommends New Shingles Vaccine FDA Panel Recommends New Shingles Vaccine
An FDA panel unanimously recommended zoster vaccine recombinant (adjuvanted) (Shingrix, GlaxoSmithKline) for adults aged 50 years and older.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Health | Infectious Diseases | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine